Post-Transplant Lymphoproliferative Disease clinical trials at UC Davis
1 in progress, 0 open to eligible people
Showing trials for
Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
Sorry, in progress, not accepting new patients
The purpose of this study is to assess the efficacy and safety of tabelecleucel in participants with EBV-associated diseases.
Sacramento, California and other locations
Last updated: